Replek AD Skopje operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Replek AD Skopje with three other
pharmaceutical manufacturers in Europe:
Amryt Pharma PLC
of the United Kingdom
sales of £11.18 million [US$15.66 million]
(150.91 million Norwegian Kroner [US$19.29 million]
of which 57%
was Hexvix/Cysview Own Sales), and
Science In Sport Plc
based in the United Kingdom
(£15.62 million [US$21.87 million]
Replek AD Skopje reported sales of 955.23 million Denar (US$19.07 million)
December of 2017.
increase of 15.2%
versus 2016, when the company's sales were 829.32 million Denar.